INS and type 2 diabetes mellitus: In T2DM, systemic insulin resistance has been shown to impair central nervous system (CNS) insulin signaling, activating multiple downstream pathways, including the mitogen-activated protein kinase (MAPK) and PI3K/Akt cascade [12,13,14].